While muscle pain is not listed as a common side effect in FDA prescribing information, some patients report muscle discomfort during treatment
Botox might also cause the skin to create less scar tissue by modulating the fibroblasts that create it and tempering the overactivation of myofibroblastscells in scar tissue that contracthelping to steer healing toward fine, flat, pliable scars. This is an off-label use of the drugand its not a go-to for the doctors I interviewedbut studies in the plastic surgery literature show that botulinum toxin injections can help reduce the width of surgical scars and improve their overall appearance
As GLP-1s gain approvals for additional disease areas - Novo is studying semaglutide in addiction, osteoarthritis, and MASHthe companies continue extending patent protection through method-of-use claims that could sustain market exclusivity well beyond initial compound patents [40]
This emulsifying action ensures gentler fat clearance without damaging the surrounding tissue
Mazdutide (Innovent Biologics) is another dual GLP-1/glucagon agonist showing promising results in Chinese patient populations
Ozempic is approved for type 2 diabetes, and Wegovy for weight loss in people who are overweight or living with obesity, at a higher maximum dose